From financial commitments to relief efforts to a nimble plan for supporting the world’s largest cities, companies like Pfizer took some smart steps in early 2020. This segment of the panel conversation will invite panelists to look critically at the initial pandemic response to inform a roadmap that can guide more inclusive responses moving forward.
It’s not enough to develop a vaccine—you have to get it out there to those who want it to build true defenses against the next pandemic. Until the whole world is vaccinated, we’re all at risk. This segment will focus on how diverse industries can work together to improve distribution, especially in underserved communities.
The reality is, this pandemic isn’t over. Even still, scientists and public healthcare experts around the world are already looking to apply what they’ve learned in the last 18 months to prepare for the next pandemic. To improve our ability to respond to future threats, we’ll look at the scientific, technical, and sociological advances that have been made due to COVID-19.